These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8101355)
21. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties. Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551 [TBL] [Abstract][Full Text] [Related]
22. Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs. Noguchi M; Skwarczynski M; Prakash H; Hirota S; Kimura T; Hayashi Y; Kiso Y Bioorg Med Chem; 2008 May; 16(10):5389-97. PubMed ID: 18440235 [TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities. Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route. Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408 [TBL] [Abstract][Full Text] [Related]
25. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism. Derry WB; Wilson L; Jordan MA Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803 [TBL] [Abstract][Full Text] [Related]
26. Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines. McDaid HM; Bhattacharya SK; Chen XT; He L; Shen HJ; Gutteridge CE; Horwitz SB; Danishefsky SJ Cancer Chemother Pharmacol; 1999; 44(2):131-7. PubMed ID: 10412947 [TBL] [Abstract][Full Text] [Related]
27. Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium. Ringel I; Horwitz SB J Pharmacol Exp Ther; 1987 Aug; 242(2):692-8. PubMed ID: 2886648 [TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of a water-soluble taxol analogue: taxol-sialyl conjugate. Takahashi T; Tsukamoto H; Yamada H Bioorg Med Chem Lett; 1998 Jan; 8(1):113-6. PubMed ID: 9925441 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir. Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278 [TBL] [Abstract][Full Text] [Related]
30. Fluorescent taxoids. Guy R; Scott Z; Sloboda R; Nicolaou K Chem Biol; 1996 Dec; 3(12):1021-31. PubMed ID: 9000007 [TBL] [Abstract][Full Text] [Related]
31. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery. Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Hassan S; Dhar S; Sandström M; Arsenau D; Budnikova M; Lokot I; Lobanov N; Karlsson MO; Larsson R; Lindhagen E Cancer Chemother Pharmacol; 2005 Jan; 55(1):47-54. PubMed ID: 15565443 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs. Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233 [TBL] [Abstract][Full Text] [Related]
35. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510 [TBL] [Abstract][Full Text] [Related]
36. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice. Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185 [TBL] [Abstract][Full Text] [Related]
37. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer. Silvestrini R; Zaffaroni N; Orlandi L; Oriana S Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system. Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel. Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492 [TBL] [Abstract][Full Text] [Related]
40. [Studies on structure modification and structure-activity relationship of new taxoids derived from sinenxan a]. Huang G; Guo J; Liang X Yao Xue Xue Bao; 1998 Aug; 33(8):576-86. PubMed ID: 12016896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]